Alkem Laboratories Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
30,672
37,014
48,572
56,261
63,260
Cost of Goods Sold (COGS) incl. D&A
19,609
23,790
29,449
33,302
38,753
Gross Income
11,063
13,224
19,122
22,959
24,507
SG&A Expense
7,643
9,505
11,641
14,095
15,853
EBIT
3,259
3,467
-
-
8,300
Unusual Expense
73
-
753
47
263
Non Operating Income/Expense
413
1,219
236
432
937
Interest Expense
931
811
712
405
501
Pretax Income
4,300
5,167
9,284
9,646
9,260
Income Tax
54
542
1,762
600
2,876
Consolidated Net Income
4,353
4,626
7,522
9,047
6,384
Net Income
4,353
4,626
7,416
8,920
6,309
Net Income After Extraordinaries
4,353
4,626
7,416
8,920
6,309
Net Income Available to Common
4,353
4,626
7,416
8,920
6,309
EPS (Basic)
36.41
38.69
62.02
74.61
52.77
Basic Shares Outstanding
120
120
120
120
120
EPS (Diluted)
36.41
38.69
62.02
74.61
52.77
Diluted Shares Outstanding
120
120
120
120
120
EBITDA
3,782
4,170
8,669
9,558
9,730
Other Operating Expense
160
253
255
317
355
Non-Operating Interest Income
1,486
1,293
1,273
1,027
787
Minority Interest Expense
-
-
106
126
75
About Alkem Laboratories
View Profile
